ARRY Stock Cash Flow Statements

Array Technologies Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Array Technologies Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31

operating activities
net income	43,262,000	16,746,000	-126,903,000	-141,354,000	25,698,000	2,165,000	23,086,000	23,214,000	-9,110,000	38,373,000	-2,777,000	-22,054,000	-27,721,000	-25,552,000	-17,000	2,887,000	-9,772,000
adjustments to reconcile net income to cash from operating activities:
benefit from bad debts	239,000	1,671,000		1,719,000	800,000	896,000
deferred tax benefit			-30,371,000	-3,778,000								6,649,000		-7,889,000	1,429,000	-71,000
depreciation and amortization	6,256,000	5,932,000	9,206,000	9,559,000	9,331,000	10,125,000	9,950,000	2,626,000	29,852,000	23,628,000	24,556,000	23,023,000	6,492,000	6,490,000	6,483,000	6,481,000	6,887,000
amortization of developed technology	3,640,000	3,639,000	3,640,000	3,639,000	3,640,000	3,639,000	3,640,000
amortization of debt discount and issuance costs	1,951,000	1,506,000	1,435,000	1,551,000	1,548,000	1,553,000	1,447,000	4,125,000	1,854,000	1,717,000	1,576,000	1,710,000	1,383,000	8,535,000	1,532,000	3,586,000	1,206,000
gain on extinguishment of debts
equity-based compensation	3,898,000	2,798,000	3,498,000	2,015,000	910,000	3,926,000	2,845,000	3,384,000	3,305,000	4,205,000	2,964,000	4,508,000	2,051,000	2,239,000	1,556,000	7,911,000
change in fair value of contingent consideration		-150,000	396,000	-39,000
warranty provision	3,616,000	1,720,000	3,127,000	97,000	1,077,000	-1,138,000	4,215,000	-28,000	-189,000	3,126,000	621,000	594,000	211,000	-120,000	123,000	302,000	320,000
inventory reserve	1,843,000	839,000
loss on disposal of fixed assets
changes in working capital	-5,547,000	-48,784,000
net cash from operating activities	43,841,000	-13,059,000	57,586,000	44,935,000	3,957,000	47,502,000	93,981,000	71,618,000			-10,667,000	-50,097,000	-97,350,000	-31,728,000	-91,961,000	-42,148,000	104,295,000
capex	-6,631,000	-2,352,000	-1,701,000	-1,077,000	-2,131,000	-2,396,000	-5,374,000	-2,191,000			-1,538,000	-2,357,000	-1,105,000	-1,052,000	-630,000	-570,000	-728,000
free cash flows	37,210,000	-15,411,000	55,885,000	43,858,000	1,826,000	45,106,000	88,607,000	69,427,000			-12,205,000	-52,454,000	-98,455,000	-32,780,000	-92,591,000	-42,718,000	103,567,000
investing activities
purchase of property, plant and equipment	-6,631,000	-2,352,000	-1,701,000	-1,077,000	-2,131,000	-2,396,000	-5,374,000	-2,191,000	-3,929,000	-2,795,000	-1,538,000	-2,357,000	-1,105,000	-1,052,000	-630,000	-570,000	-728,000
retirement/disposal of property, plant and equipment			-4,000	-1,000	29,000	10,000
net cash from investing activities	-6,631,000	-2,352,000	-15,981,000	10,897,000	-2,102,000	-2,386,000	-5,206,000	-2,191,000	-3,931,000	-2,793,000	-1,540,000	-376,173,000	-1,105,000	-1,052,000	-2,605,000	-10,570,000	-728,000
financing activities
proceeds from issuance of other debt	49,202,000	7,862,000	74,035,000	6,340,000	10,401,000	2,283,000	2,795,000	36,715,000	-19,031,000	8,620,000	24,370,000	6,229,000
proceeds from issuance of convertible notes
premium paid on capped call
fees paid on issuance of convertible notes
repayments of other debt
repayments of term loan facility
repayments of convertible notes
contingent consideration payments	0	-1,204,000	0	0	0	-1,427,000	0	0
other financing	-1,109,000	-14,000
net cash from financing activities	-11,051,000	-1,725,000	397,000	-8,097,000	431,000	-4,575,000	-17,319,000	-45,128,000	-24,706,000	-89,551,000	21,961,000	100,736,000	349,734,000	131,489,000	93,115,000	-36,590,000	-22,270,000
effect of exchange rate changes on cash and cash equivalent balances	3,118,000	2,488,000	-10,233,000	2,317,000	-7,586,000	-2,001,000	3,614,000	-6,255,000	2,290,000	-711,000	-8,199,000	7,355,000
net change in cash and cash equivalents and restricted cash	29,277,000	-14,648,000
cash and cash equivalents, and restricted cash beginning of period	0	364,141,000
cash and cash equivalents and restricted cash, end of period	29,277,000	349,493,000
deferred tax expense		1,024,000						-532,000		-10,944,000
principal payments on other debt		-7,294,000	-72,545,000	-12,208,000	-8,890,000	-3,781,000	-19,039,000	-30,767,000
principal payments on term loan facility		-1,075,000	-1,075,000	-1,075,000	-1,080,000	-1,070,000	-1,075,000	-51,075,000					-1,075,000	-101,075,000	-1,075,000	-30,000,000
operating activities:
adjustments to net income
goodwill impairment			74,000,000
impairment of long-lived assets
allowance for credit losses
gain on debt refinancing
write-down of inventories			442,000	1,254,000	627,000	600,000	1,844,000	1,129,000
changes in operating assets and liabilities, net of business acquisition:
accounts receivable			-442,000	43,244,000	-97,369,000	95,990,000	99,164,000	74,675,000	62,052,000	-27,424,000	-67,344,000	-44,268,000	-58,654,000	-23,829,000	-31,673,000	-2,692,000	-698,000
inventories			-14,823,000	-22,757,000	4,335,000	-11,542,000	54,189,000	-10,290,000	35,143,000	62,918,000	-30,941,000	-46,250,000	-32,863,000	-34,878,000	-14,197,000	-6,246,000	-20,652,000
income tax receivables			33,000	-2,832,000	-1,315,000	2,000	-3,156,000	-55,000	9,221,000	3,452,000	14,862,000	-21,924,000	-2,599,000	3,204,000	-5,502,000	13,003,000	-640,000
prepaid expenses and other			-24,505,000	-41,750,000	-1,234,000	-2,219,000	-8,700,000	1,152,000	7,978,000	11,522,000	-6,336,000	5,960,000	-15,456,000	-6,596,000	4,042,000	-3,216,000	-6,121,000
accounts payable			24,475,000	36,637,000	20,959,000	-23,891,000	-52,097,000	-16,099,000	-29,538,000	-32,440,000	15,094,000	59,551,000	6,689,000	3,326,000	9,178,000	-10,556,000	31,765,000
accrued expenses and other			34,492,000	-19,756,000	35,397,000	-50,569,000	-13,159,000	11,387,000	-40,247,000	37,915,000	-3,671,000	7,027,000	7,450,000	12,224,000	-15,675,000	5,134,000	6,269,000
income tax payable			3,790,000	-1,969,000	-3,619,000	935,000	2,674,000	-10,568,000	-3,706,000	7,553,000	4,158,000	-8,760,000	-569,000	629,000	-10,224,000	1,410,000	286,000
lease liabilities			-2,894,000	-2,595,000	-663,000	-2,472,000	9,227,000	-9,464,000	1,870,000	-2,786,000	-1,385,000	6,085,000	-116,000	269,000	-179,000	247,000
deferred revenue			8,443,000	20,050,000	6,820,000	20,250,000	-33,821,000	-14,053,000	24,230,000	-12,491,000	65,902,000	-18,639,000	17,855,000	29,889,000	-38,422,000	-59,941,000	105,040,000
investing activities:
cash payments for the acquisition of right-of-use assets
acquisition of sti, net of cash acquired									-2,000	2,000	-2,000	-373,816,000
safe investment
sale of equity investment			0
financing activities:
proceeds from series a issuance									0	0	0	33,098,000	0
proceeds from common stock issuance									0	0	0	15,885,000	0
series a equity issuance costs								-1,000	-726,000	-592,000	-400,000	-175,000	0
tax withholding related to vesting of equity-based compensation			-18,000	-1,154,000	0	-580,000
common stock issuance costs									0	0	0	-450,000	0
dividends paid on series a preferred									0
payments on revolving credit facility									0	-83,000,000			-24,033,000
proceeds from revolving credit facility									0	15,000,000	49,000,000	52,000,000	24,033,000	0
net change in cash and cash equivalents			31,769,000	50,052,000	-5,300,000	38,540,000	75,070,000	18,044,000	71,123,000	11,732,000	1,555,000	-318,179,000	251,279,000
cash and cash equivalents and restricted cash, beginning of period
supplemental cash flow information
cash paid for interest			8,989,000				7,813,000	20,256,000
cash paid for income taxes			2,746,000				9,145,000	18,313,000
non-cash investing and financing activities
dividends accrued on series a preferred			7,246,000				6,803,000	6,696,000
stock consideration paid for acquisition of sti									0	0	0	200,224,000
adjustments to net income:
cash and cash equivalents, beginning of period				0	0	249,080,000	0	0	0	0	0	367,670,000	0
cash and cash equivalents, end of period							75,070,000	18,044,000	71,123,000	11,732,000	1,555,000	49,491,000	251,279,000
deferred tax (benefit) expense						-13,000											927,000
contingent consideration gain						-735,000
benefit from (recovery of) bad debts							2,644,000		1,939,000	150,000	365,000	145,000	107,000	-23,000	-16,000	-535,000	102,000
contingent consideration							732,000	189,000	1,474,000	-572,000	-1,678,000	-3,731,000	1,625,000	936,000	-13,000	148,000	10,433,000
retirement/disposal of pp&e
investment in equity securities
series a equity issuance costs and commitment fees
debt issuance costs													0	0	0	-6,590,000
change in fair value of derivative assets								-116,000
warranty payments
dividends on series a preferred
interest paid-in-kind																	0
benefit from inventory obsolescence									1,474,000	-2,742,000	0	409,000	336,000	-582,000			-1,292,000
changes in operating assets and liabilities, net of acquisition
investment in equity security													0	0	-1,975,000	-10,000,000
proceeds from term loan facility
payments on related party loans																	0
payment of special distribution
deferred offering costs																	-2,689,000
cash flows from operating activities
adjustments to reconcile net income to net cash provided by, (used in) operating activities:
changes in operating assets and liabilities, net of business acquisition
accounts payable - related party										0	0	-132,000	0	0
net cash provided by, (used in) operating activities
cash flows from investing activities
cash flows from financing activities
principal payments on debt										-10,909,000	-18,009,000	-4,368,000
adjustments to reconcile net income to net cash from operating activities:
cash flows used in (provided by) operating activities
adjustments to reconcile net income to net cash from (provided by) operating activities:
changes in operating assets and liabilities
cash flows used in investing activities
principal payments on term loan																	0
proceeds from (payments on) revolving loan																	-102,000
proceeds from issuance of common stock, net of underwriting discount and commissions
capital contribution
cash flows used in operating activities
net decrease in cash, cash equivalents and restricted cash															-1,451,000	-89,308,000
cash, cash equivalents and restricted cash, beginning of period															0	108,441,000
cash, cash equivalents, and restricted cash, end of period															-1,451,000	19,133,000
changes in operating assets and liabilities:
internal-use software modification costs
proceeds from related party loan
debt discount and financing costs
proceeds from issuance of class a common stock, net of underwriting discount and commissions
net increase in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash, beginning of year
cash, cash equivalents and restricted cash, end of year
equity based compensation
net decrease in cash and restricted cash
cash and restricted cash, beginning of year
cash and restricted cash, end of year
raw materials
finished goods
reserve for excess or obsolete inventory
total

We provide you with 20 years of cash flow statements for Array Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Array Technologies stock. Explore the full financial landscape of Array Technologies stock with our expertly curated income statements.

The information provided in this report about Array Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.